Molecular Diagnostics Market Research Report
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
List of Tables<br />
1. Impact Analysis of <strong>Market</strong> Drivers<br />
2. Impact Analysis of <strong>Market</strong> Restraints<br />
3. Classification rules of IVDs under the IVDR<br />
4. Registration Criteria for IVD Medical Devices as<br />
per the CFDA<br />
5. Genetic Tests for Certain Applications<br />
6. Examples of <strong>Molecular</strong> <strong>Diagnostics</strong> in Cancer<br />
7. North America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017-2028<br />
8. Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017-2028<br />
9. APAC <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017-2028<br />
10. Latin America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017-2028<br />
11. RoW <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017-2028<br />
List of Figures<br />
1. Global Precision Medicine <strong>Market</strong>, 2016 and 2020<br />
2. Impact of <strong>Market</strong> Drivers and <strong>Market</strong> Restraints on<br />
the Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
3. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> Snapshot<br />
4. Dominating Segments of the Global <strong>Molecular</strong><br />
<strong>Diagnostics</strong> <strong>Market</strong>, 2017 and 2028<br />
5. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Product),<br />
2017 and 2028<br />
6. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Product),<br />
2017<br />
7. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Product),<br />
2028<br />
8. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Technology), 2017 and 2028<br />
9. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Technology), 2017 and 2028<br />
10. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Technology), 2017 and 2028<br />
11. Role of <strong>Diagnostics</strong> in Healthcare<br />
12. Evolution of <strong>Molecular</strong> <strong>Diagnostics</strong><br />
13. Classification of <strong>Molecular</strong> <strong>Diagnostics</strong><br />
14. Global <strong>Molecular</strong> <strong>Diagnostics</strong> (MDx) <strong>Market</strong>, 2017-<br />
2028<br />
15. Iceberg Analysis - Global <strong>Molecular</strong> <strong>Diagnostics</strong><br />
<strong>Market</strong><br />
16. Number of Deaths by Top 18 Infectious Diseases,<br />
2015<br />
17. Strategies to Integrate Personalized Medicine for<br />
Routine Healthcare Procedures<br />
18. Benefits of Multiplexing Reactions<br />
19. Share of Key Developments and Strategies, January<br />
2016 - December 2018<br />
20. Synergistic Activities Share (by Companies), January<br />
2016 - December 2018<br />
21. Approvals Share (by Companies), January 2016 -<br />
December 2018<br />
22. Product Launches and Enhancements Share (by<br />
Companies), January 2016 - December 2018<br />
23. Acquisitions Share (by Companies), January 2016 -<br />
December 2018<br />
sales@bisresearch.com | www.bisresearch.com
Change language